Adam Cohen
Adam D. Cohen, MD, is the Director of Myeloma Immunotherapy, Amyloidosis Program Co-Director, and Associate Professor of Medicine at the Abramson Cancer Center at the University of Pennsylvania. His research focuses on clinical development of novel therapies, particularly immunotherapies, for patients with myeloma, AL amyloidosis and other plasma cell dyscrasias.
Dr Cohen's attendance is supported by Janssen
If you have any queries about the Meeting arrangements please don’t hesitate to contact us on:
Email: blood@theconferencecompany.com
Telephone (NZ): +64 9 360 1240
Freephone (Aus): 1800 193 405
Postal Address: PO Box 90 040 Auckland, 1142 New Zealand
Street Address: Level 35, International Tower One 100 Barangaroo Avenue, Sydney, NSW, 2000, Australia
Copyright © 2022 Blood 2023 / Meeting is managed by The Conference Company Designed & Developed by The Conference Company